Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Lucid Group shares climbed about 12% on Tuesday after Uber disclosed it holds an 11.52% stake in the electric vehicle manufacturer following a $200 million investment announced last week. A regulatory filing shows Uber now owns roughly 37.8 million Lucid shares, making it the automaker's second-largest shareholder behind the Public Investment Fund …
Boston, April 21 - A federal judge in Boston has issued a preliminary injunction preventing the Trump administration from enforcing a set of permitting policies that industry and advocacy groups say have effectively stalled wind and solar project development across the United States. Plaintiffs argued a July Interior Department memorandum and relat…
Regeneron Pharmaceuticals reported positive Phase 3 NIMBLE trial results for cemdisiran, an investigational siRNA therapy targeting complement factor 5 (C5), demonstrating rapid, deep, and sustained disease control in adults with generalized myasthenia gravis (gMG). The trial met primary and key secondary endpoints at 24 weeks, showing significant …
Zentalis Pharmaceuticals announced that an abstract highlighting results from Part 1 of their MUIR trial, testing azenosertib in combination with paclitaxel for platinum-resistant ovarian cancer, has been accepted for presentation at the ASCO 2026 Annual Meeting. Azenosertib, a first-in-class WEE1 inhibitor, is being developed as a biomarker-driven…
Skyworks Solutions, Inc. will release its second quarter fiscal 2026 earnings on May 5, 2026, followed by a conference call to discuss results and business outlook. The company provides analog and mixed-signal semiconductors across various sectors including wireless networking, aerospace, automotive, and consumer electronics.
Immatics N.V. announced that four abstracts from its clinical cell therapy and bispecific T-cell engager pipeline have been selected for oral presentations at the 2026 ASCO Annual Meeting. Data highlights include Phase 1b results of anzu-cel in melanoma, updated Phase 1a/b data for second-generation IMA203CD8 in gynecologic cancers, findings on PRA…
Banco de Brasilia (BRB) has signed a memorandum of understanding with Quadra Capital to form an investment vehicle that will take on assets tied to transactions BRB received from Banco Master, with a reference value of 15 billion reais ($2.9 billion). The MoU, released late on Monday, outlines a mix of cash and subordinated shares as consideration …
Dar Al Balad Business Solutions Co., a Saudi IT services provider founded in 2001, is moving ahead with an initial share sale on the kingdom’s exchange. A shareholder plans to offer 21 million shares - a 30% stake - in an institutional book-building scheduled for April 26-30, arranged by AlJazira Capital and Emirates NBD. The sale is expected to ra…
Candel Therapeutics (CADL) looks like a constructive buy right now. Positive clinical readouts, a funded commercialization push and bullish technical momentum have pushed the stock toward a new 52-week high. With market cap near $545M, meaningful cash on the balance sheet and a clear product roadmap, a disciplined long position offers asymmetric up…
The U.S. Senate Banking, Housing, and Urban Affairs Committee has opened confirmation hearings for President Trump's nominee to lead the Federal Reserve, Kevin Warsh. Senators and markets are watching for signals about the Fed's likely interest-rate trajectory and broader questions about the central bank's independence after a Justice Department pr…
Goldman Sachs initiated coverage of Dynatrace and Elastic, assigning a buy rating and $45 price target to Dynatrace and a neutral rating with a $50 target to Elastic. Analyst Matthew Martino argues that AI is intensifying the strategic role of machine data, favoring platforms that can scale compute and move from monitoring to autonomous remediation…
Avis Budget Holdings climbed to an all-time share price high after a dramatic run in April driven largely by a short squeeze. With more than four-fifths of the free float reported shorted and two large holders controlling the bulk of outstanding shares, technical dynamics have amplified price moves even as analysts flag underlying fundamentals and …
An anticipated SpaceX IPO at a $1.75 trillion valuation and a jaw-dropping 220x EV/EBITDA multiple could catalyze a broad re-rating across aerospace & defense. That repricing would lift multiples for primes, launch suppliers, and satellite-capable contractors. Tactical trade: go long the iShares U.S. Aerospace & Defense ETF (ITA) to capture a secto…
Ganesan Satish, Senior Vice President and Chief Strategy Officer at Synaptics Inc., sold two blocks of company stock in mid-April 2026. One sale on April 20 was executed under a pre-established 10b5-1 trading plan; a separate April 17 disposition satisfied tax withholding on settled restricted stock units. The company also reported fiscal second-qu…
Lisa Bodensteiner, Synaptics' Senior Vice President, Chief Legal Officer and Corporate Secretary, sold 1,798 shares of company stock on April 20, 2026 under a pre-arranged 10b5-1 plan for about $147,200. Separately, 4,210 shares were withheld by Synaptics on April 17, 2026 to cover tax withholdings tied to RSU settlement. The company's latest quart…
Qfin trades at bargain-bin multiples and an eye-catching 10%+ yield, yet a tightening regulatory environment for consumer lending in China has turned tomorrow’s earnings and dividend into catalysts and potential landmines. This trade idea targets a mid-term rebound while respecting regulatory uncertainty and the upcoming ex-dividend date.
Aprea Therapeutics announced that early results from their first-in-human Phase 1 trial of the WEE1 inhibitor APR-1051 in advanced solid tumor patients have been accepted for presentation at the 2026 ASCO Annual Meeting. This milestone highlights progress in developing targeted therapies for biomarker-defined cancers and underscores the company's f…
NextCure, Inc. announced that Phase 1 clinical data for SIM0505, an investigational antibody drug conjugate targeting Cadherin-6 for the treatment of advanced solid tumors, will be presented at ASCO 2026. The results underscore forward progress in NextCure's oncology pipeline, focusing on innovative therapies for cancer including difficult-to-treat…
Vikram Gupta, Senior Vice President & General Manager, Edge Compute & Connectivity Division and Chief Product Officer at Synaptics Inc (NASDAQ: SYNA), executed a 10b5-1 plan sale of 1,548 shares on April 20, 2026 for $125,310. Three days earlier he had 5,518 shares withheld to satisfy tax obligations tied to restricted stock units. Following these …
IP Strategy Holdings, Inc. has announced a 1-for-20 reverse stock split of its common stock effective April 23, 2026, aimed at complying with Nasdaq's minimum bid price requirements and improving stock liquidity. The reverse split will adjust shares and outstanding warrants proportionately without affecting authorized shares or shareholder rights e…
Agnico Eagle's string of strategic buys — including consolidation in Finland and the Fingold purchase — materially expands low-risk, high-return optionality. At a $105.7B market cap and a P/E of 24.3, the stock already reflects quality; I argue the market is under-pricing the production and synergy upside from the new district consolidation. Action…
Patria has strengthened scale and diversified revenue with three sizeable acquisitions that materially lift Fee-Earning AUM and Fee Related Earnings. The stock is a buy from a fundamentals perspective, but after a busy M&A stretch I favor a tactical, size-conscious long with a clear stop and a mid- to multi-month target.
Anthropic is preparing to extend access to its Mythos artificial intelligence model to banks in Europe and the UK, according to people familiar with the matter. The move follows an initial distribution of the model to a cohort of U.S. financial institutions and infrastructure partners. Regulators and policymakers have raised cybersecurity warnings …
UBS is advising investors to concentrate on individual copper producers with identifiable catalysts and valuation upside rather than adopting a broad sector stance, as copper prices rally to near-record levels. While the bank retains a constructive structural view on copper driven by supply constraints and energy transition demand, it warns that ne…
SKYX Platforms (SKYX) has stacked strategic partnerships, retail launches, and institutional capital in recent quarters. That combination creates a clear mid-term re-rating pathway if deployments and AI-enabled features gain commercial traction. At the same time the company is unprofitable, burning cash, and sitting in a crowded short-interest prof…
